Based on the ALAN quantitative outputs, RSPO2 behaved similarly to EMT-related genes and FGFR1/2, but exhibited opposing behavior with AR regulatory genes and MYC, a pan-cancer oncogene (Figure 4B–4D). The gene discussed is AR; the disease is cancer.